Aptamers' Potential to Fill Therapeutic and Diagnostic Gaps

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2024 Jan 23

PMID 38256938

Authors

Alfredo Berzal-Herranz

Cristina Romero-Lopez

Affiliations

Soon will be listed here.

Abstract

More than 30 years ago, in 1990, three independent research groups published several papers demonstrating that genetics could be performed in vitro in the absence of living organisms or cells [...].

References

Kotkowiak W, Jahnz-Wechmann Z, Pasternak A . A Comprehensive Analysis of the Thrombin Binding Aptamer Containing Functionalized Pyrrolo-2'-deoxycytidines. Pharmaceuticals (Basel). 2021; 14(12). PMC: 8709445. DOI: 10.3390/ph14121326. View

Carvalho J, Mergny J, Salgado G, Queiroz J, Cruz C . G-quadruplex, Friend or Foe: The Role of the G-quartet in Anticancer Strategies. Trends Mol Med. 2020; 26(9):848-861. DOI: 10.1016/j.molmed.2020.05.002. View

Sharma T, Bruno J, Dhiman A . ABCs of DNA aptamer and related assay development. Biotechnol Adv. 2017; 35(2):275-301. DOI: 10.1016/j.biotechadv.2017.01.003. View

Durand G, Dausse E, Goux E, Fiore E, Peyrin E, Ravelet C . A combinatorial approach to the repertoire of RNA kissing motifs; towards multiplex detection by switching hairpin aptamers. Nucleic Acids Res. 2016; 44(9):4450-9. PMC: 4872101. DOI: 10.1093/nar/gkw206. View

Blind M, Blank M . Aptamer Selection Technology and Recent Advances. Mol Ther Nucleic Acids. 2017; 4:e223. PMC: 4345306. DOI: 10.1038/mtna.2014.74. View

Nimjee S, Rusconi C, Sullenger B . Aptamers: an emerging class of therapeutics. Annu Rev Med. 2005; 56:555-83. DOI: 10.1146/annurev.med.56.062904.144915. View

Zhu G, Chen X . Aptamer-based targeted therapy. Adv Drug Deliv Rev. 2018; 134:65-78. PMC: 6239901. DOI: 10.1016/j.addr.2018.08.005. View

Zhang T, Liu J, Zhang L, Irfan M, Su X . Recent advances in aptamer-based biosensors for potassium detection. Analyst. 2023; 148(21):5340-5354. DOI: 10.1039/d3an01053h. View

Valbuena A, Sanz-Garcia M, Lopez-Sanchez I, Vega F, Lazo P . Roles of VRK1 as a new player in the control of biological processes required for cell division. Cell Signal. 2011; 23(8):1267-72. DOI: 10.1016/j.cellsig.2011.04.002. View

10.

Zhang T, Jin X, Zhang N, Jiao X, Ma Y, Liu R . Targeted drug delivery vehicles mediated by nanocarriers and aptamers for posterior eye disease therapeutics: barriers, recent advances and potential opportunities. Nanotechnology. 2021; 33(16). DOI: 10.1088/1361-6528/ac46d5. View

11.

Kratschmer C, Levy M . Effect of Chemical Modifications on Aptamer Stability in Serum. Nucleic Acid Ther. 2017; 27(6):335-344. PMC: 5706619. DOI: 10.1089/nat.2017.0680. View

12.

Marton S, Reyes-Darias J, Sanchez-Luque F, Romero-Lopez C, Berzal-Herranz A . In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules. Molecules. 2010; 15(7):4610-38. PMC: 6257598. DOI: 10.3390/molecules15074610. View

13.

Leaderer D, Cashman S, Kumar-Singh R . Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration. Exp Eye Res. 2015; 140:171-178. PMC: 4640196. DOI: 10.1016/j.exer.2015.09.005. View

14.

Robertson D, Joyce G . Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature. 1990; 344(6265):467-8. DOI: 10.1038/344467a0. View

15.

Lee M, Shin S, Kim S, Park N . Recent Advances in Biological Applications of Aptamer-Based Fluorescent Biosensors. Molecules. 2023; 28(21). PMC: 10647268. DOI: 10.3390/molecules28217327. View

16.

Kizilkurtlu A, Demirbas E, Agel H . Electrochemical aptasensors for pathogenic detection toward point-of-care diagnostics. Biotechnol Appl Biochem. 2023; 70(4):1460-1479. DOI: 10.1002/bab.2485. View

17.

Drees A, Trinh T, Fischer M . The Influence of Protein Charge and Molecular Weight on the Affinity of Aptamers. Pharmaceuticals (Basel). 2023; 16(3). PMC: 10054347. DOI: 10.3390/ph16030457. View

18.

Park S, Cho E, Chueng S, Yoon J, Lee T, Lee J . Aptameric Fluorescent Biosensors for Liver Cancer Diagnosis. Biosensors (Basel). 2023; 13(6). PMC: 10296440. DOI: 10.3390/bios13060617. View

19.

Romero-Lopez C, Berzal-Herranz B, Gomez J, Berzal-Herranz A . An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication. Antiviral Res. 2012; 94(2):131-8. DOI: 10.1016/j.antiviral.2012.02.015. View

20.

Huang W, Cui X, Chen Y, Shao M, Shao X, Shen Y . High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma. Pathol Res Pract. 2015; 212(3):171-8. DOI: 10.1016/j.prp.2015.11.015. View